Antibacterial IgM is better at activating the complement system than IgG and the mechanism by which this occurs is different between these two types of antibodies. In addition, IgM can provide broader protection against different bacteria than IgG via a newly identified cross-reactivity mechanism.
More
NCOH on X
;
Follow-up of chronic Q fever patients should be continued in order to obtain better long-term epidemiological insights in this potentially deadly infection, concluded Bianca Buijs, MD from @UMCUtrecht in her PhD thesis that she defended recently https://edu.nl/447at
Researchers from @Amsterdamumc, @UMCUtrecht, @UniLeidenNews and @UCSD have discovered an important immune component that may offer protection against infection with the pathogen Staphylococcus aureus. The results were published recently in @CellRepMed
https://edu.nl/6vfqb
Sorry, there are no upcoming NCOH Events at the moment...
NCOH bundles One Health top research
The Netherlands Centre for One Health (NCOH) aims for an integrated One Health approach to tackle the global risk of infectious diseases. NCOH commits to create durable solutions for this major challenge by bundling world-leading academic top research in the Netherlands in the area of One Health.
Young NCOH
Young NCOH is the network for PhD students and post-docs from the NCOH research groups. Aim of the network is sharing knowledge and expertise in One Health related disciplines, which can lead to new collaborations in research.
Complementary research themes
The 4 NCOH strategic research themes are complementary and interactive. They focus on studying the interactions and connections between human, veterinary, wildlife, and environmental health. The focus of NCOH is on (re-)emerging infectious diseases, epidemics, and antimicrobial resistance, including veterinary and environmental challenges. Its objective is to find sustainable solutions for global One Health challenges. How NCOH and its researchers accomplish this, you can read in our NCOH interactive brochure.
NCOH is partner in the Netherlands Antibiotic Development Platform (NADP).
Our partners
